About
Treatments for GRIN-related disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
108
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2RECRUITING: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06975605Lead Sponsor
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
PHASE1Active, not recruiting
18 participants
Started: May 20, 2025 · Completed: Aug 30, 2025
NCT06965881Lead Sponsor
Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults
PHASE1Recruiting
36 participants
Started: May 8, 2025 · Completed: Sep 30, 2025
NCT06392009Lead Sponsor
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 10, 2024 · Completed: Jul 31, 2026
NCT05818943Lead Sponsor
Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
PHASE1Active, not recruiting
24 participants
Started: Mar 7, 2023 · Completed: Nov 30, 2026
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...